TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+140.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+140.4%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
13.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 101.52% |
| 2023 | -1080.51% |
| 2022 | 97.24% |
| 2021 | 7.31% |
| 2020 | 3.76% |
| 2019 | -55.13% |
| 2018 | -40.25% |
| 2017 | -10.14% |
| 2016 | 12.53% |
| 2015 | -73.64% |